181 related articles for article (PubMed ID: 31495240)
1. Safety of testosterone therapy in men with prostate cancer.
Morgentaler A; Caliber M
Expert Opin Drug Saf; 2019 Nov; 18(11):1065-1076. PubMed ID: 31495240
[No Abstract] [Full Text] [Related]
2. Is testosterone a friend or a foe of the prostate?
Jannini EA; Gravina GL; Morgentaler A; Morales A; Incrocci L; Hellstrom WJ
J Sex Med; 2011 Apr; 8(4):946-55. PubMed ID: 21457469
[TBL] [Abstract][Full Text] [Related]
3. Testosterone therapy in prostate cancer: is it still a controversy?
Bart AS; Van Hoof A; Badre-Hume R; Selvarajah J; Robillard K; Albala DM
Curr Opin Urol; 2022 Nov; 32(6):598-606. PubMed ID: 36081393
[TBL] [Abstract][Full Text] [Related]
4. Testosterone Therapy After Prostate Cancer Treatment: A Review of Literature.
Natale C; Carlos C; Hong J; Khera M; Baum N; Raheem OA
Sex Med Rev; 2021 Jul; 9(3):393-405. PubMed ID: 33516741
[TBL] [Abstract][Full Text] [Related]
5. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
Rodriguez KM; Pastuszak AW; Khera M
Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
[TBL] [Abstract][Full Text] [Related]
6. A new era of testosterone and prostate cancer: from physiology to clinical implications.
Khera M; Crawford D; Morales A; Salonia A; Morgentaler A
Eur Urol; 2014 Jan; 65(1):115-23. PubMed ID: 24011426
[TBL] [Abstract][Full Text] [Related]
7. Trends in Testosterone Therapy use in Prostate Cancer Survivors in the United States.
Chen T; Li S; Eisenberg ML
J Sex Med; 2021 Aug; 18(8):1346-1353. PubMed ID: 34303630
[TBL] [Abstract][Full Text] [Related]
8. How the rise of testosterone therapy in men was inspired by lizard research with David Crews.
Morgentaler A
J Exp Zool A Ecol Integr Physiol; 2022 Jan; 337(1):103-106. PubMed ID: 34878221
[TBL] [Abstract][Full Text] [Related]
9. Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.
Balbontin FG; Moreno SA; Bley E; Chacon R; Silva A; Morgentaler A
BJU Int; 2014 Jul; 114(1):125-30. PubMed ID: 25101359
[TBL] [Abstract][Full Text] [Related]
10. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
Morales A
BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.
Morgentaler A; Traish A; Hackett G; Jones TH; Ramasamy R
Sex Med Rev; 2019 Oct; 7(4):636-649. PubMed ID: 31351915
[TBL] [Abstract][Full Text] [Related]
12. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
13. Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.
Morgentaler A; Conners WP
Asian J Androl; 2015; 17(2):206-11. PubMed ID: 25652633
[TBL] [Abstract][Full Text] [Related]
14. Testosterone therapy in men with untreated prostate cancer.
Morgentaler A; Lipshultz LI; Bennett R; Sweeney M; Avila D; Khera M
J Urol; 2011 Apr; 185(4):1256-60. PubMed ID: 21334649
[TBL] [Abstract][Full Text] [Related]
15. The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy.
Xie T; Song XL; Wang C; Yu YZ; Wang JQ; Chen ZS; Zhao SC
Drug Discov Today; 2021 May; 26(5):1293-1301. PubMed ID: 33561465
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and prostate cancer: revisiting old paradigms.
Isbarn H; Pinthus JH; Marks LS; Montorsi F; Morales A; Morgentaler A; Schulman C
Eur Urol; 2009 Jul; 56(1):48-56. PubMed ID: 19375844
[TBL] [Abstract][Full Text] [Related]
17. Testosterone Therapy in Advanced Prostate Cancer.
Chedrawe E; Sathe A; White J; Ory J; Ramasamy R
Androg Clin Res Ther; 2022; 3(1):180-186. PubMed ID: 36684061
[TBL] [Abstract][Full Text] [Related]
18. Controversies in Testosterone Therapy.
Twitchell DK; Pastuszak AW; Khera M
Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
[TBL] [Abstract][Full Text] [Related]
19. Current state of practice regarding testosterone supplementation therapy in men with prostate cancer.
Kovac JR; Pan MM; Lipshultz LI; Lamb DJ
Steroids; 2014 Nov; 89():27-32. PubMed ID: 25072793
[TBL] [Abstract][Full Text] [Related]
20. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer.
Lopez DS; Huang D; Tsilidis KK; Canfield S; Khera M; Baillargeon JG; Kuo YF; Peek MK; Platz EA; Markides K
Cancer Causes Control; 2021 Sep; 32(9):965-976. PubMed ID: 34041642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
